首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 吕海涛
2022
CA
Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer
Pharmacol Res, 10.1016/j.phrs.2022.106554
CA
Functional metabolomics revealed functional metabolic-characteristics of chronic hepatitis that is significantly differentiated from acute hepatitis in mice
Pharmacol Res, 10.1016/j.phrs.2022.106248
CA
Emerging pharmacotherapy for inflammatory bowel diseases
Pharmacol Res, 10.1016/j.phrs.2022.106146
2021
CA
Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism
Pharmacol Res, 10.1016/j.phrs.2021.105767
点击查看热心肠日报解读
CA
Microbial Metabolomics: From Methods to Translational Applications
ADV EXP MED BIOL, 10.1007/978-3-030-51652-9_7
CA
Functional metabolomics innovates therapeutic discovery of traditional Chinese medicine derived functional compounds
PHARMACOL THERAPEUT, 10.1016/j.pharmthera.2021.107824
2020
CA
Mass spectrometry based targeted metabolomics precisely characterized new functional metabolites that regulate biofilm formation in Escherichia coli
ANAL CHIM ACTA, 10.1016/j.aca.2020.12.021
CA
Precision-characterization and quantitative determination of main compounds in Si-Ni-San with UHPLC-MS/MS based targeted-profiling method
J PHARMACEUT BIOMED, 10.1016/j.jpba.2020.113816
CA
Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites
Pharmacol Res, 10.1016/j.phrs.2020.105358
点击查看热心肠日报解读